In papillary thyroid cancer, RNA sequencing studies revealed that the presence of BRAF mutation is associated with a reduced expression of immune/inflammatory response genes as compared with wild type-BRAF tumors [24]. The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.